Iradimed (IRMD) Non-Current Assets (2013 - 2026)

Iradimed (IRMD) has 14 years of Non-Current Assets data on file, last reported at $28.0 million in Q1 2026.

• On a quarterly basis, Non-Current Assets rose 5.17% year-over-year to $28.0 million in Q1 2026; TTM through Mar 2026 was $114.4 million, a 33.03% increase from a year earlier, with the FY2025 full-year figure at $27.6 million, up 19.45% from the prior year.
• Non-Current Assets for Q1 2026 stood at $28.0 million, up from $27.6 million in the prior quarter.
• Over the last five years, Non-Current Assets for IRMD reached as high as $29.8 million in Q3 2025 and fell as low as $6.9 million in Q1 2022.
• Historically, Non-Current Assets has averaged $18.1 million across 5 years, with a median of $16.2 million in 2023.
• Across the five-year window, Non-Current Assets decreased 1.39% in 2022 and surged 112.21% in 2023, its largest moves.
• Year by year, Non-Current Assets stood at $8.0 million in 2022, then surged by 101.33% to $16.2 million in 2023, then soared by 42.89% to $23.1 million in 2024, then climbed by 19.45% to $27.6 million in 2025, then gained by 1.43% to $28.0 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $28.0 million in Q1 2026, $27.6 million in Q4 2025, and $29.8 million in Q3 2025.